May 5, 2022
Sponsored by Maypro
Sirtmax® has been developed to target SIRT1 gene, known as the “longevity gene”. It helps protect the mitochondria from decay and influences numerous genes that relate to aging effects.
The effects of the SIRT1 gene may sound like that of those found in Resveratrol, which has been a favorite for anti-aging researchers. However, Sirtmax is proven to be 5 times more potent than Resveratrol, making it the perfect partner for low-dose mechanisms.
In a double-blind placebo human clinical trial, Sirtmax was found to successfully support a reduction in bodyweight, help maintain blood sugar levels within a normal level, support the decrease production of advanced glycation end products, and support improvement in arterial flexibility.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023